Plasmodium vivax: Comparison of immunogenicity among proteins expressed in the cell-free systems of Escherichia coli and wheat germ by suspension array assays

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Rui, Edmilson ^a   Fernandez Becerra, Carmen ^a   Takeo, Satoru ^b   Sanz, Sergi ^a   Lacerda, Marcus Vg ^c   Tsuboi, Takafumi ^b   Del Portillo, Hernando A ^a,d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b EHIME UNIVERSITY   (Japan)

^c Fundacao de Medicina Tropical Dr Heitor Vieira Dourado   (Brazil)

^d INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ANTISERUM; GLUTATHIONE TRANSFERASE; PLASMODIUM VIVAX ANTIGEN; PLASMODIUM VIVAX PROTEIN; PROTEIN; PVCSP S PROTEIN; PVDBP RII PROTEIN; PVMSP1 19 PROTEIN; PVMSP1 NTER PROTEIN; PVMSP5 PROTEIN; PVMSP7 PROTEIN; UNCLASSIFIED DRUG; PARASITE ANTIGEN; PROTOZOAL PROTEIN; PROTOZOON ANTIBODY;

ADULT; ARTICLE; ASSAY; CELL FREE SYSTEM; CONTROLLED STUDY; ESCHERICHIA COLI; HUMAN; IMMUNOGENICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM VIVAX; PROTEIN EXPRESSION; SUSPENSION ARRAY ASSAY; WHEAT GERM; BIOSYNTHESIS; BLOOD; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; WHEAT;

ADULT; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CELL-FREE SYSTEM; ESCHERICHIA COLI; HUMANS; PLASMODIUM VIVAX; PROTOZOAN PROTEINS; TRITICUM;

EID: 79960559732     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-192     Document Type: Article

References (36)

1. A research agenda to underpin malaria eradication. PL Alonso, G Brown, M Arevalo-Herrera, F Binka, C Chitnis, F Collins, OK Doumbo, B Greenwood, BF Hall, MM Levine, K Mendis, RD Newman, CV Plowe, MH Rodríguez, R Sinden, L Slutsker, M Tanne, PLoS Med 2011 8 1000406 10.1371/journal.pmed.1000406 21311579
2. The international limits and population at risk of Plasmodium vivax transmission in 2009. CA Guerra, RE Howes, AP Patil, PW Gething, TP Van Boeckel, WH Temperley, CW Kabaria, AJ Tatem, BH Manh, IR Elyazar, JK Baird, RW Snow, SI Hay, PLoS Negl Trop Dis 2010 4 774 10.1371/journal.pntd.0000774 20689816
3. The neglected burden of Plasmodium vivax malaria. K Mendis, BJ Sina, P Marchesini, R Carter, Am J Trop Med Hyg 2001 64 97 106 11425182 (Pubitemid 32552576)
4. The global distribution and population at risk of malaria: past, present, and future. SI Hay, CA Guerra, AJ Tatem, AM Noor, RW Snow, Lancet Infect Dis 2004 4 327 336 10.1016/S1473-3099(04)01043-6 15172341 (Pubitemid 38692697)
5. Clinical features of children hospitalized with malaria - a study from Bikaner, northwest India. DK Kochar, GS Tanwar, PC Khatri, SK Kochar, GS Sengar, A Gupta, A Kochar, S Middha, J Acharya, V Saxena, D Pakalapati, S Garg, A Das, Am J Trop Med Hyg 2010 83 981 989 10.4269/ajtmh.2010.09-0633 21036824
6. Severe Plasmodium vivax malaria, Brazilian Amazon. MA Alexandre, CO Ferreira, AM Siqueira, BL Magalhaes, MP Mourao, MV Lacerda, MG Alecrim, Emerg Infect Dis 2010 16 1611 1614 20875292
7. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. I Mueller, MR Galinski, JK Baird, JM Carlton, DK Kochar, PL Alonso, HA del Portillo, Lancet Infect Dis 2009 9 555 566 10.1016/S1473-3099(09)70177-X 19695492
8. Current status of Plasmodium vivax vaccine. M Arevalo-Herrera, C Chitnis, S Herrera, Hum Vaccin 2010 6 124 132 10.4161/hv.6.1.9931 20009526
9. Comparative genomics of the neglected human malaria parasite Plasmodium vivax. JM Carlton, JH Adams, JC Silva, SL Bidwell, H Lorenzi, E Caler, J Crabtree, SV Angiuoli, EF Merino, P Amedeo, Q Cheng, RM Coulson, BS Crabb, HA Del Portillo, K Essien, TV Feldblyum, C Fernandez-Becerra, PR Gilson, AH Gueye, X Guo, S Kang'a, TW Kooij, M Korsinczky, EV Meyer, V Nene, I Paulsen, O White, SA Ralph, Q Ren, TJ Sargeant, SL Salzberg, CJ Stoeckert, SA Sullivan, MM Yamamoto, SL Hoffman, JR Wortman, MJ Gardner, MR Galinski, JW Barnwell, CM Fraser-Liggett, Nature 2008 455 757 763 10.1038/nature07327 18843361
10. Heterologous expression of proteins from Plasmodium falciparum: results from 1000 genes. C Mehlin, E Boni, FS Buckner, L Engel, T Feist, MH Gelb, L Haji, D Kim, C Liu, N Mueller, PJ Myler, JT Reddy, JN Sampson, E Subramanian, WC Van Voorhis, E Worthey, F Zucker, WG Hol, Mol Biochem Parasitol 2006 148 144 160 10.1016/j.molbiopara.2006.03.011 16644028 (Pubitemid 43964865)
11. Efficiency of cell-free protein synthesis based on a crude cell extract from Escherichia coli, wheat germ, and rabbit reticulocytes. M Hino, M Kataoka, K Kajimoto, T Yamamoto, J Kido, Y Shinohara, Y Baba, J Biotechnol 2008 133 183 189 10.1016/j.jbiotec.2007.08.008 17826860 (Pubitemid 350278636)
12. Utilization of genomic sequence information to develop malaria vaccines. DL Doolan, JC Aguiar, WR Weiss, A Sette, PL Felgner, DP Regis, P Quinones-Casas, JR Yates, PL Blair, TL Richie, SL Hoffman, DJ Carucci, J Exp Biol 2003 206 3789 3802 10.1242/jeb.00615 14506214 (Pubitemid 37365461)
13. A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. PD Crompton, MA Kayala, B Traore, K Kayentao, A Ongoiba, GE Weiss, DM Molina, CR Burk, M Waisberg, A Jasinskas, X Tan, S Doumbo, D Doumtabe, Y Kone, DL Narum, X Liang, OK Doumbo, LH Miller, DL Doolan, P Baldi, PL Felgner, SK Pierce, Proc Natl Acad Sci USA 2010 107 6958 6963 10.1073/pnas.1001323107 20351286
14. Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates. T Tsuboi, S Takeo, H Iriko, L Jin, M Tsuchimochi, S Matsuda, ET Han, H Otsuki, O Kaneko, J Sattabongkot, R Udomsangpetch, T Sawasaki, M Torii, Y Endo, Infect Immun 2008 76 1702 1708 10.1128/IAI.01539-07 18268027 (Pubitemid 351562015)
15. The wheat germ cell-free protein synthesis system: a key tool for novel malaria vaccine candidate discovery. T Tsuboi, S Takeo, TU Arumugam, H Otsuki, M Torii, Acta Trop 2010 114 171 176 10.1016/j.actatropica.2009.10.024 19913490
16. Immunoproteomics profiling of blood stage Plasmodium vivax infection by high-throughput screening assays. JH Chen, JW Jung, Y Wang, KS Ha, F Lu, CS Lim, S Takeo, T Tsuboi, ET Han, J Proteome Res 2010 9 6479 6489 10.1021/pr100705g 20949973
17. Multiplex assay for simultaneous measurement of antibodies to multiple Plasmodium falciparum antigens. GG Fouda, RF Leke, C Long, P Druilhe, A Zhou, DW Taylor, AH Johnson, Clin Vaccine Immunol 2006 13 1307 1313 10.1128/CVI.00183-06 17035513 (Pubitemid 46086895)
18. A semi-automated multiplex high-throughput assay for measuring IgG antibodies against Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) domains in small volumes of plasma. GK Cham, J Kurtis, J Lusingu, TG Theander, AT Jensen, L Turner, Malar J 2008 7 108 10.1186/1475-2875-7-108 18549480 (Pubitemid 352001003)
19. High throughput functional assays of the variant antigen PfEMP1 reveal a single domain in the 3D7 Plasmodium falciparum genome that binds ICAM1 with high affinity and is targeted by naturally acquired neutralizing antibodies. AV Oleinikov, E Amos, IT Frye, E Rossnagle, TK Mutabingwa, M Fried, PE Duffy, PLoS Pathog 2009 5 1000386 10.1371/journal.ppat.1000386 19381252
20. Naturally-acquired humoral immune responses against the N- and C-termini of the Plasmodium vivax MSP1 protein in endemic regions of Brazil and Papua New Guinea using a multiplex assay. C Fernandez-Becerra, S Sanz, M Brucet, DI Stanisic, FP Alves, EP Camargo, PL Alonso, I Mueller, HA del Portillo, Malar J 2010 9 29 10.1186/1475-2875-9-29 20092651
21. Suspension array technology: evolution of the flat-array paradigm. JP Nolan, LA Sklar, Trends Biotechnol 2002 20 9 12 10.1016/S0167-7799(01)01844-3 11742671 (Pubitemid 34015902)
22. Characterization of naturally acquired human IgG responses against the N-terminal region of the merozoite surface protein 1 of Plasmodium vivax. G Levitus, F Mertens, MA Speranca, LM Camargo, MU Ferreira, HA del Portillo, Am J Trop Med Hyg 1994 51 68 76 8059917 (Pubitemid 24266290)
23. Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax. R Rosenberg, RA Wirtz, DE Lanar, J Sattabongkot, T Hall, AP Waters, C Prasittisuk, Science 1989 245 973 976 10.1126/science.2672336 2672336 (Pubitemid 19224827)
24. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. MM Bradford, Anal Biochem 1976 72 248 254 10.1016/0003-2697(76)90527-3 942051
25. An efficient approach to the production of vaccines against the malaria parasite. T Tsuboi, S Takeo, T Sawasaki, M Torii, Y Endo, Methods Mol Biol 2010 607 73 83 10.1007/978-1-60327-331-2-8 20204850
26. Making the most of affinity tags. DS Waugh, Trends Biotechnol 2005 23 316 320 10.1016/j.tibtech.2005.03.012 15922084 (Pubitemid 40726273)
27. Merozoite surface proteins of the malaria parasite: the MSP1 complex and the MSP7 family. M Kadekoppala, AA Holder, Int J Parasitol 2010 40 1155 1161 10.1016/j.ijpara.2010.04.008 20451527
28. Targeting the Plasmodium vivax Duffy-binding protein. CE Chitnis, A Sharma, Trends Parasitol 2008 24 29 34 10.1016/j.pt.2007.10.004 18023618
29. Circumsporozoite protein of Plasmodium vivax: gene cloning and characterization of the immunodominant epitope. DE Arnot, JW Barnwell, JP Tam, V Nussenzweig, RS Nussenzweig, V Enea, Science 1985 230 815 818 10.1126/science.2414847 2414847 (Pubitemid 16193972)
30. Heterologous expression of plasmodial proteins for structural studies and functional annotation. LM Birkholtz, G Blatch, TL Coetzer, HC Hoppe, E Human, EJ Morris, Z Ngcete, L Oldfield, R Roth, A Shonhai, L Stephens, AI Louw, Malar J 2008 7 197 10.1186/1475-2875-7-197 18828893
31. Human protein factory for converting the transcriptome into an in vitro-expressed proteome. N Goshima, Y Kawamura, A Fukumoto, A Miura, R Honma, R Satoh, A Wakamatsu, J Yamamoto, K Kimura, T Nishikawa, T Andoh, Y Iida, K Ishikawa, E Ito, N Kagawa, C Kaminaga, K Kanehori, B Kawakami, K Kenmochi, R Kimura, M Kobayashi, T Kuroita, H Kuwayama, Y Maruyama, K Matsuo, K Minami, M Mitsubori, M Mori, R Morishita, A Murase, A Nishikawa, S Nishikawa, T Okamoto, N Sakagami, Y Sakamoto, Y Sasaki, T Seki, S Sono, A Sugiyama, T Sumiya, T Takayama, Y Takayama, H Takeda, T Togashi, K Yahata, H Yamada, Y Yanagisawa, Y Endo, F Imamoto, Y Kisu, S Tanaka, T Isogai, J Imai, S Watanabe, N Nomura, Nat Methods 2008 5 1011 1017 10.1038/nmeth.1273 19054851
32. From the circumsporozoite protein to the RTS, S/AS candidate vaccine. J Cohen, V Nussenzweig, R Nussenzweig, J Vekemans, A Leach, Hum Vaccin 2010 6 90 96 10.4161/hv.6.1.9677 19806009
33. Distribution of Plasmodium vivax variants (VK210, VK247 and P. vivax-like) in three endemic areas of the Amazon region of Brazil and their correlation with chloroquine treatment. RL Machado, MM Povoa, Trans R Soc Trop Med Hyg 2000 94 377 381 10.1016/S0035-9203(00)90110-X 11127238 (Pubitemid 30662343)
34. High polymorphism in Plasmodium vivax merozoite surface protein-5 (MSP5). A Gomez, CF Suarez, P Martinez, C Saravia, MA Patarroyo, Parasitology 2006 133 661 672 10.1017/S0031182006001168 16978450 (Pubitemid 44763962)
35. The transcriptome of Plasmodium vivax reveals divergence and diversity of transcriptional regulation in malaria parasites. Z Bozdech, S Mok, G Hu, M Imwong, A Jaidee, B Russell, H Ginsburg, F Nosten, NP Day, NJ White, JM Carlton, PR Preiser, Proc Natl Acad Sci USA 2008 105 16290 16295 10.1073/pnas.0807404105 18852452
36. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection. CL King, P Michon, AR Shakri, A Marcotty, D Stanisic, PA Zimmerman, JL Cole-Tobian, I Mueller, CE Chitnis, Proc Natl Acad Sci USA 2008 105 8363 8368 10.1073/pnas.0800371105 18523022 (Pubitemid 351904761)